Aft, Forsyth & Company, Inc. Novo Nordisk A S Transaction History
Aft, Forsyth & Company, Inc.
- $174 Million
- Q1 2024
A detailed history of Aft, Forsyth & Company, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Aft, Forsyth & Company, Inc. holds 3,125 shares of NVO stock, worth $444,000. This represents 0.23% of its overall portfolio holdings.
Number of Shares
3,125
Previous 3,125
-0.0%
Holding current value
$444,000
Previous $323,000
24.15%
% of portfolio
0.23%
Previous 0.2%
Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,878Shares Held
309MCall Options Held
5.36MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.95 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.85 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.71 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.68 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $321B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...